文献速递糖尿病

中国早发2型糖尿病人群中PDX1变异所致糖尿病的患病率与临床特征

Prevalence and Clinical Characteristics of PDX1 Variant Induced Diabetes in Chinese Early-Onset Type 2 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

该研究纳入679例临床诊断为早发2型糖尿病的中国患者,通过DNA测序筛查PDX1突变,结合功能实验与美国医学遗传学与基因组学学会指南判定致病性,共识别4例MODY4,占0.59%。结合既往病例分析显示,同源域变异携带者较转录激活域变异携带者诊断年龄更早,错义突变者中超重和肥胖比例高于无义或移码突变者。

要点

  • 中国早发2型糖尿病队列中MODY4患病率为0.59%(4/679)。
  • 同源域变异携带者诊断年龄早于转录激活域变异携带者(26.10±11.00 vs 41.85±14.66岁,P<.001)。
  • 错义突变者超重和肥胖比例高于无义或移码突变者(27/34[79.4%] vs 3/8[37.5%],P=.031)。

核心结论

  • 研究提示MODY4在中国早发2型糖尿病人群中患病率为0.59%。
  • MODY4因临床与早发2型糖尿病相似而较其他MODY亚型更难临床识别。
  • 研究显示PDX1基因型与临床表型之间存在一定关系。

研究设计与样本

  • 研究队列由679例临床诊断为早发2型糖尿病的中国患者组成。
  • 通过DNA测序筛查PDX1突变,并用功能实验和美国医学遗传学与基因组学学会指南评估致病性。
  • 携带致病或可能致病PDX1变异者诊断为MODY4,并回顾所有已报告病例分析基因型-表型关系。

主要发现

  • 共识别4例MODY4患者,占该中国早发2型糖尿病队列的0.59%。
  • 所有MODY4患者诊断年龄均小于35岁,体型有肥胖也有非肥胖。
  • 同源域变异携带者诊断年龄早于转录激活域变异携带者(26.10±11.00 vs 41.85±14.66岁,P<.001)。
  • 错义突变者中超重和肥胖比例高于无义或移码突变者(27/34[79.4%] vs 3/8[37.5%],P=.031)。

关键数值与推荐

  • MODY4诊断标准为携带致病或可能致病PDX1变异且患有糖尿病。
  • 同源域变异携带者诊断年龄26.10±11.00岁 vs 转录激活域变异携带者41.85±14.66岁(P<.001)。
  • 错义突变者超重和肥胖比例27/34(79.4%) vs 无义或移码突变者3/8(37.5%)(P=.031)。

临床怎么用

  • 作者认为MODY4在中国早发2型糖尿病人群中患病率为0.59%,临床与早发2型糖尿病相似而较其他MODY亚型更难识别。
  • 作者认为PDX1基因型与临床表型之间存在一定关系。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Maturity-onset diabetes of the young 4 (MODY4) is caused by mutations of PDX1; its prevalence and clinical features are not well known. OBJECTIVE: This study aimed to investigate the prevalence and clinical characteristics of MODY4 in Chinese people clinically diagnosed with early-onset type 2 diabetes (EOD), and to evaluate the relationship between the PDX1 genotype and the clinical phenotype. METHOD: The study cohort consisted of 679 patients with EOD. PDX1 mutations were screened by DNA sequencing, and their pathogenicity was evaluated by functional experiments and American College of Medical Genetics and Genomics guidelines. MODY4 was diagnosed in individuals with diabetes who carry a pathogenic or likely pathogenic PDX1 variant. All reported cases were reviewed for analyzing the genotype-phenotype relationship. RESULT: 4 patients with MODY4 were identified, representing 0.59% of this Chinese EOD cohort. All the patients were diagnosed before 35 years old, either obese or not obese. Combined with previously reported cases, the analysis revealed that the carriers of homeodomain variants were diagnosed earlier than those with transactivation domain variants (26.10 ± 11.00 vs 41.85 ± 14.66 years old, P < .001), and the proportions of overweight and obese individuals with missense mutation were higher than those with nonsense or frameshift mutations (27/34 [79.4%] vs 3/8 [37.5%], P = .031). CONCLUSION: Our study suggested that MODY4 was prevalent in 0.59% of patients with EOD in a Chinese population. It was more difficult to identify clinically than other MODY subtypes owning to its clinical similarity to EOD. Also, this study revealed that there is some relationship between genotype and phenotype.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Lian H, Gong S, Li M, et al. Prevalence and Clinical Characteristics of PDX1 Variant Induced Diabetes in Chinese Early-Onset Type 2 Diabetes. J Clin Endocrinol Metab. 2023. PMID: 37279936. doi:10.1210/clinem/dgad303

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。